We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Skinbiotherapeutics Plc | LSE:SBTX | London | Ordinary Share | GB00BF33H870 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.25 | 9.00 | 9.50 | 9.50 | 9.25 | 9.25 | 122,323 | 10:38:51 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 132k | -2.84M | -0.0163 | -5.67 | 16.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/4/2019 07:33 | thats a success not a duster, someuwin. So using our product improved skin faster in all groups, and the more damaged your skin is (or older ), it has a greater effect/ improvement. Makes sense, healthy skin does not need it, however the older you are the worse your skin gets through natural aging and sunlight damage, so it will improve skin for this age group....their the ones that need it anyway. | belgrano2 | |
08/4/2019 07:17 | The change in skin hydration and water loss are IN LINE WITH OUR EXPECTATIONS from laboratory studies which have shown that SkinBiotix(R) increases the levels of proteins within the skin that are crucial for a healthy barrier. | parob | |
08/4/2019 07:16 | In O&G terms - this looks like a duster to me. | someuwin | |
08/4/2019 07:07 | Dr Cath O'Neill, CEO of SkinBioTherapeutics, said:"We are really pleased by these data. To show efficacy at this stage of development is very exciting since there is a lot of scope for us to further optimise the formulation, potentially altering the dose of the SkinBiotix(R) to make it more suitable for different age groups.It is very difficult to change a healthy barrier and therefore the data showing improvement in some age groups gives us confidence in our partner discussions, and in seeking to develop future applications in disease conditions where the barrier is known to be poor such as eczema". | parob | |
08/4/2019 07:06 | Not great results imho | f3rdinand | |
06/4/2019 08:16 | Good skin results here over the next couple of weeks should give OPTI an extra boost and the timing couldn't be better as the share price breaks out. | parob | |
05/4/2019 17:19 | Awful time to sell imo. All signs point to good news from results. Someone bottling it by looks of it. | riskybusiness1 | |
05/4/2019 16:17 | There it is the 125K share sale that has been holding us back today. | rafboy | |
05/4/2019 15:59 | Should easily break through by next week. Results should be out next week/week after. If they're good this will see reach new highs | riskybusiness1 | |
05/4/2019 15:12 | 20 resistance can't be that strong. Its blasted past it 2 times out 3 and both hit 29p. | slartybartfaster | |
05/4/2019 13:17 | 20p has strong resistance. Once it breaks after a few more buys should move up to mid 20s pretty swiftly I would hope. | riskybusiness1 | |
05/4/2019 12:44 | IMO, the share price should be around 21-22p today but I think there is a 100k plus seller still around. | gostaa | |
05/4/2019 12:28 | Yes must be as if all these buys were sales we would be 5% down by now | onedayrodders | |
05/4/2019 11:49 | There must be another 100k background sell given the stagnant share price today after what appears to be a lot of buys. | gostaa | |
05/4/2019 11:32 | Must be due a tick up after all the buys this morning. | rafboy | |
04/4/2019 08:36 | Stand back ... she's alive at long last :o) | onedayrodders | |
03/4/2019 15:20 | Not really. It allowed me to add at almost half the price i was willing to pay. | slartybartfaster | |
03/4/2019 12:56 | looking good ..shame we lost that momentum in mid Feb and had to start again | onedayrodders | |
03/4/2019 11:51 | Who said I don’t have shares? If the tech works then there’ll be a bun fight to get exclusivity. Could well end in TO, hopefully a share buyout 🤪 | pretax2 | |
03/4/2019 10:09 | Good to see the buyers this morning, not long to wait. | rafboy | |
02/4/2019 19:51 | Pretax2 it must be very reassuring to yourself that you don’t own any shares then. I can’t see this company being sold out any time soon. All I can see is a big jump up in share price within the next few weeks. | jamesrs1 | |
02/4/2019 17:35 | If it’s nailed on that’s probably the reason the share price is where it is. This company is just simply waiting for takeover | pretax2 | |
02/4/2019 16:29 | It's pretty obvious there isn't any issues. All major milestone were past quite quickly. The last possible stumbling block was increased dose to test irritancy if there was a need to increase the dose. This also passed. We also know nobody has left the trials which is another plus. Nailed on success imo. | slartybartfaster |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions